180 Life Sciences Corp. (NASDAQ: ATNF) stock jumped 45.12% on Friday to $0.83 against a previous-day closing price of $0.57. With 0.68 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.32 million shares. The 52-week range on ATNF shows that it touched its highest point at $18.00 and its lowest point at $0.51 during that stretch. It currently has a 1-year price target of $80.00.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ATNF was up-trending over the past week, with a rise of 49.13%, but this was up by 29.25% over a month. Three-month performance dropped to -28.69% while six-month performance fell -61.35%. The stock lost -94.85% in the past year, while it has lost -75.60% so far this year.
Float and Shares Shorts:
At present, 5.98 million ATNF shares are outstanding with a float of 5.50 million shares on hand for trading. On Aug 30, 2023, short shares totaled 0.14 million, which was 2.42% higher than short shares on Jul 30, 2023. In addition to Sir Marc Feldmann Ph.D. as the firm’s Co-Founder & Exec. Co-Chairman, Dr. Lawrence Steinman BA, M.D., Ph.D. serves as its Co-Founder & Exec. Co-Chairman.
Through their ownership of 4.16% of ATNF’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 6.81% of ATNF, in contrast to 1.85% held by mutual funds. Shares owned by individuals account for 0.97%. As the largest shareholder in ATNF with 2.01% of the stake, Renaissance Technologies LLC holds 119,995 shares worth 119,995. A second-largest stockholder of ATNF, The Vanguard Group, Inc., holds 15,379 shares, controlling over 0.26% of the firm’s shares. BlackRock Fund Advisors is the third largest shareholder in ATNF, holding 14,236 shares or 0.24% stake. With a 0.80% stake in ATNF, the Vanguard Extended Market Index Fu is the largest stakeholder. A total of 47,852 shares are owned by the mutual fund manager. The Fidelity Extended Market Index Fu, which owns about 0.10% of ATNF stock, is the second-largest Mutual Fund holder. It holds 5,656 shares valued at 3773.0. Fidelity Total Market Index Fund holds 0.03% of the stake in ATNF, owning 1,915 shares worth 1277.0.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, ATNF reported revenue of $0.00 and operating income of -$4.52M. The EBITDA in the recently reported quarter was -$4.50M and diluted EPS was $1.72.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ATNF since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With ATNF analysts setting a high price target of $80.00 and a low target of $80.00, the average target price over the next 12 months is $80.00. Based on these targets, ATNF could surge 9538.55% to reach the target high and rise by 9538.55% to reach the target low. Reaching the average price target will result in a growth of 9538.55% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded ATNF stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 11 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 224,727 while 0 shares were sold.